Related Experiment Video
Updated: Aug 14, 2026

Germ Cell Transplantation and Testis Tissue Xenografting in Mice
Published on: February 6, 2012
Pearls and perils in the management of germ cell tumors
Cynthia X Wei1, Lawrence H Einhorn, Nabil Adra
1Division of Hematology and Medical Oncology - Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Purpose Of Review:
Research and innovation over the past half century have rendered testicular cancer a highly curable malignancy. Challenges and uncertainty remain in several aspects related to the management and surveillance of patients with germ cell tumors (GCT). Long-term effects of treatment on survivors of testicular cancer remain as continued areas of interest. This review aims to highlight pearls and perils in the management of patients with GCT.
Recent Findings:
Uncertainty remain regarding complex aspects of first-line and salvage treatments of GCT, interpretation of tumor markers in cases of α-fetoprotein levels less than 25 ng/ml, plateau of β-human chorionic gonadotropin (hCG) levels in patients with initial hCG greater than 50 000 mIU/ml, supportive therapies throughout chemotherapy regimens, and long-term survivorship of patients who underwent surgery or received platinum-based chemotherapy. This review aims to highlight challenges that remain in GCT, review the emerging data in these areas, and provide our institutional opinion on the management in several aspects of GCT.
Summary:
Testicular cancer continues to present challenging clinical scenarios with respect to treatment, surveillance, and long-term management of patients. We review the data and share our institutional knowledge in several challenging areas related to the management of GCT.
Insights
Testicular cancer (germ cell tumors) is highly curable, but challenges persist in treatment, surveillance, and long-term care for survivors. This review addresses these complex management aspects and offers insights for improved patient outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Testicular cancer, or germ cell tumors (GCT), has seen significant advancements making it highly curable.
- Despite progress, complex challenges persist in managing GCT patients and survivors.
Purpose of the Study:
- To review current challenges in testicular cancer (GCT) management and surveillance.
- To highlight pearls and perils in GCT patient care, focusing on treatment, tumor marker interpretation, and long-term survivorship.
Main Methods:
- Literature review of current research and emerging data in GCT management.
- Synthesis of institutional knowledge and expert opinion on challenging clinical scenarios.
Main Results:
- Uncertainties exist in first-line and salvage GCT treatments.
- Complexities arise in interpreting tumor markers (AFP, hCG) and managing supportive therapies.
- Long-term effects of surgery and chemotherapy on survivors require continued attention.
Conclusions:
- Testicular cancer management presents ongoing clinical challenges.
- Addressing these complexities is crucial for optimizing patient outcomes and survivorship.
- This review provides insights into navigating difficult aspects of GCT care.

